Bayesian Capital Management’s Revvity RVTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-34,922
Closed -$3.67M 1052
2024
Q1
$3.67M Buy
+34,922
New +$3.72M 0.35% 69
2023
Q4
Sell
-7,500
Closed -$830K 994
2023
Q3
$830K Buy
+7,500
New +$881K 0.09% 258
2023
Q2
Sell
-6,550
Closed -$873K 1028
2023
Q1
$873K Sell
6,550
-7,500
-53% -$988K 0.11% 260
2022
Q4
$1.97M Buy
14,050
+10,400
+285% +$1.4M 0.29% 64
2022
Q3
$439K Buy
+3,650
New +$515K 0.09% 314
2022
Q2
Sell
-1,400
Closed -$244K 1037
2022
Q1
$244K Buy
+1,400
New +$249K 0.04% 594
2021
Q2
Sell
-8,300
Closed -$1.06M 615
2021
Q1
$1.06M Buy
8,300
+2,400
+41% +$332K 0.25% 106
2020
Q4
$847K Buy
+5,900
New +$785K 0.22% 127
2016
Q3
Sell
-13,356
Closed -$700K 480
2016
Q2
$700K Buy
+13,356
New +$702K 0.42% 63

Other funds holding RVTY

Bayesian Capital Management's RVTY Position: Q2 2024 in Review

Bayesian Capital Management sold out of Revvity (RVTY) in Q2 2024, closing a stake of 34,922 shares — an estimated $3.67M sold.

Bayesian Capital Management first reported a position in RVTY in Q2 2016 and held it in 9 quarters. The position peaked at $3.67M in Q1 2024. 483 funds tracked by Wall St. Rank hold RVTY as of Q2 2024.

  • Bayesian Capital Management reported no remaining Revvity position as of Q2 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 34,922 Revvity shares in Q2 2024, an estimated $3.67M.
  • Bayesian Capital Management first reported a position in Revvity in Q2 2016 and held it in 9 quarters.
  • Bayesian Capital Management's Revvity position peaked at $3.67M in Q1 2024.
  • 483 funds tracked by Wall St. Rank held Revvity as of Q2 2024.

Based on Bayesian Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.